Enliven Therapeutics

IPO

Enliven Therapeutics is a biotech company in Boulder, United States, founded in 2019. It has raised $305.0M across 3 rounds, most recently a $165.0M Corporate Round in February 2023.

Small Molecule Kinase Inhibitors

Headquarters
Boulder
Employees
51–200
Founded
2019
Business Model
B2B
Total Funding
$305.0M
Last Round
$165.0M Corporate RoundFeb 2023
Rounds
3
Type
Public

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 3 funding rounds and 2 investors for this company. The full record is or through the API.

About

Enliven Therapeutics is a clinical-stage biopharmaceutical company headquartered in Boulder, Colorado, founded in July 2019 by Sam Kintz, Joe Lyssikatos, and Anish Patel. The company discovers and develops small molecule kinase inhibitor therapies for cancer, including lead program ELVN-001 targeting BCR-ABL alongside a second program directed at HER2, designed to overcome resistance mechanisms seen with existing therapies as part of its mission to help patients not only live longer, but live better.

Summary

It lists 51–200 employees. It has raised $305.0M in total across 3 rounds, most recently a $165.0M Corporate Round in Feb 2023. Investors include OrbiMed and Fairmount.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Data from Indexed.vcUpdated
Secondary MarketSecondary Market2024 (est.)

Sign up to see all 4 events

Funding: Series A through Corporate Round. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Enliven Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/enliven-therapeutics"><img src="https://indexed.vc/api/badge/company/enliven-therapeutics" alt="Enliven Therapeutics on Indexed.vc" width="260" height="76" /></a>